BIO-key and Multipoint GROUP Join Forces to Promote Cybersecurity and Identity Solutions to High-Growth Global Markets in Europe and the Middle East

Partnership includes distribution, pre-sales, training, and full support to resellers and customers

WALL, N.J. and MADRID, Spain, Sept. 12, 2022 (GLOBE NEWSWIRE) — BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB), today announced a distribution partnership with Israel-based Multipoint GROUP in Southern and Central Europe and the Middle East. Multipoint has joined BIO-key’s Channel Alliance Partner (CAP) program designed to leverage the expertise, reach and onsite presence of a range of leading IT service providers that deliver security solutions to their customers. BIO-key continues to expand worldwide customer support through its growing Channel Alliance Partner community, and this new partnership with Multipoint further strengthens BIO-key’s presence in important regions.

The Multipoint partnership provides BIO-key with a strategic value-added distributor of cybersecurity with solid technical experience and a knowledgeable commercial sales team. Multipoint offers not only distribution but also pre-sales analysis, training, and full support to resellers and customers interested in security and identity solutions. Multipoint operates in 15 countries, including Greece, Cyprus, the United Arab Emirates, Romania, Bulgaria, Estonia, Poland, Malta, , Turkey, and Portugal as well as Singapore. Both new and existing customers of all sizes and industries in these regions can benefit with enterprise-grade security IAM solutions that are phoneless, tokenless, and passwordless.

BIO-key’s Channel Alliance Partner program allows its partners to represent BIO-key’s full line of biometric authentication solutions and large-scale identity management security products that provide robust Single Sign-on (SSO) and Multi-factor (MFA) authentication capabilities. The BIO-key suite of products also includes a full line of compact biometric fingerprint scanners that are Microsoft tested and qualified to support Windows Hello and Windows 10 and 11.

“Multipoint remains committed to partnering with cyber companies that offer advanced cyber solutions, that are aware of the latest threats and adapt their solutions accordingly, such as advanced IAM and MFA solutions. We believe BIO-Key offers one of the best security solutions on the market. This collaboration provides a platform for exchanging knowledge and aspirations to reduce cyber threats together,” said Ricardo Resnik, CEO & Founder of Multipoint GROUP.

“Multipoint has a proven track record as a value-added distributor for delivering quality cyber security solutions. Their core focus is on high-quality security products and vendors, and as such, Multipoint Group and BIO-Key are a perfect match. This partnership will support BIO-key’s strong growth in market share in the countries where Multipoint Group is currently active and should also drive substantial new revenue growth in new regional markets as they expand their footprint,” said Erik Notermans, VP of Sales for BIO-key in Europe.

“We are excited about our partnership with Multipoint because both leadership teams share the same values and vision for future market opportunities in Southern and Central Europe and the Middle East. We continue to develop strong partner alliances through our CAP program that deliver new business to BIO-key and strengthen our customer support worldwide,” said Alex Rocha, Managing Director of EMEA at BIO-key.

About BIO-key International, Inc. (www.BIO-key.com)

BIO-key has over two decades of expertise in providing authentication technology for thousands of organizations and millions of users and is revolutionizing authentication with biometric-centric, multi-factor identity and access management (IAM) solutions, including its PortalGuard IAM solution that provides convenient and secure access to devices, information, applications, and high-value transactions. BIO-key’s patented software and hardware solutions, with industry-leading biometric capabilities, enable large-scale on-premises and cloud-based Identity-as-a-Service (IDaaS) solutions, as well as customized enterprise solutions. BIO-key EMEA (formerly Swivel Secure Europe, S.A) is a 100% owned BIO-key IAM solutions provider based in Madrid, Spain, that serves the European, Middle East, and African markets.

BIO-key Safe Harbor Statement
All statements contained in this press release other than statements of historical facts are “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 (the “Act”). The words “estimate,” “project,” “intends,” “expects,” “anticipates,” “believes,” and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management’s beliefs, as well as assumptions made by, and information currently available to, management pursuant to the “safe harbor” provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue; our ability to raise additional capital; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology industry; market acceptance of biometric products generally and our products under development; the duration and severity of the current coronavirus COVID-19 pandemic and its effect on our business operations, sales cycles, personnel, and the geographic markets in which we operate; delays in the development of products and statements of assumption underlying any of the foregoing as well as other factors set forth under the caption see “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2021 and other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, the Company undertakes no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise. Additionally, there may be other factors of which the Company is not currently aware that may affect matters discussed in forward-looking statements and may also cause actual results to differ materially from those discussed. In particular, the consequences of the coronavirus outbreak to economic conditions and the industry in general and the financial position and operating results of our Company, in particular, have been material, are changing rapidly, and cannot be predicted.

Engage with BIO-key:�
Facebook – Corporate:	https://www.facebook.com/BIOkeyInternational/
LinkedIn – Corporate:	https://www.linkedin.com/company/bio-key-international
Twitter – Corporate:	@BIOkeyIntl
Twitter – Investors:	@BIO_keyIR
StockTwits:	BIO_keyIR

BIO-key Media Contact:
Erin Knapp
Matter Communications
BIO-key@matternow.com
914-260-3158

Investor Contacts:
William Jones, David Collins
Catalyst IR
BKYI@catalyst-ir.com
212-924-9800